* Syneos Health Inc SYNH.OQ SYNH.O is expected to show a
rise
in quarterly revenue when it reports results on February 17.
* The Morrisville North Carolina-based company is expected
to
report a 23.3% increase in revenue to $1.406 billion from $1.14
billion a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Syneos Health Inc
is for
earnings of $1.43 per share. For the same quarter last year, the
company reported earnings of $1.11 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Syneos
Health Inc
is $112, about 20.6% above its last closing price
of $88.97.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2021 1.17 1.17 1.22 Beat 4.4
Jun. 30 2021 0.95 0.95 0.97 Beat 2.4
Mar. 31 2021 0.74 0.75 0.79 Beat 5.8
Dec. 31 2020 1.10 1.10 1.11 Beat 0.6
Sep. 0.92 0.91 1.04 Beat 14.4
30 2020
Jun. 30 2020 0.48 0.48 0.58 Beat 20.3
Mar. 31 2020 0.62 0.62 0.68 Beat 9.3
Dec. 31 2019 1.01 1.01 1.03 Beat 2
This summary was machine generated February 15 at 13:51 GMT.
All figures in US dollars unless otherwise stated